EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sodium bicarbonate administration for metabolic acidosis in the intensive care unit: a target trial emulation

Sebastiaan Paul Blank, Ruth Miriam Blank, Kevin B Laupland, Alexis Tabah, Denzil Gill, Aashish Kumar, Kyle White, Antony Attokaran, Stephen Luke, Stephen Whebell, Peter Garrett, James McCullough und 3 weitere

Intensive Care Medicine · 2025-06 · 51 (6) · 1078-1086

DOI: 10.1007/s00134-025-07979-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intensive Care Medicine, online erschienen am 10.06.2025. Verfasst von Sebastiaan Paul Blank und 14 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, Cairns Hospital, Cairns, Australia. Hauptthemen laut MEDLINE: Sodium Bicarbonate, Acidosis. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Queensland University of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Sodium bicarbonate is commonly administered to treat metabolic acidosis in intensive care units (ICUs). There is limited evidence from randomized trials to support this practice, and observational studies show conflicting results. Our aim was to perform a target trial emulation evaluating the effect of bicarbonate therapy on mortality. METHODS: Retrospective cohort study using data from 12 Australian ICUs. Inclusion criteria were adults with pH < 7.3 and PCO2 ≤ 45 mmHg within the first three days. We excluded repeat admissions, toxicology, diabetic ketoacidosis, and pre-existing end-stage renal failure. The treatment intervention was sodium-bicarbonate administration, and the primary outcome was 30-day ICU mortality with ICU discharge as a competing event. We evaluated multiple subgroups, including patients with acute kidney injury, requirement for vasoactive therapy, and pH < 7.2. The primary model utilized a parametric g-computation and rolling entry matching was performed as a sensitivity analysis. RESULTS: We identified 6157 eligible admissions, of which 1764 (29%) received sodium bicarbonate. Bicarbonate therapy was associated with a 1.9% absolute mortality reduction for the primary analysis [risk ratio 0.86, 95% confidence interval (CI) 0.80 to 0.91], and significant benefits were seen across all subgroups evaluated. A similar point estimate of 2.1% was observed in the sensitivity analysis, with a sustained mortality reduction seen at 30 days. CONCLUSION: In this target trial emulation, bicarbonate administration was associated with a small but statistically significant reduction in mortality for patients with metabolic acidosis. Large sample sizes would be required to demonstrate this effect in a randomized trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium BicarbonateAcidosisHumansIntensive Care UnitsRetrospective StudiesMaleFemaleMiddle AgedAustraliaAgedHospital MortalityAdult

Stichwörter der Autor:innen

Acute kidney injuryCritical careMetabolic acidosisSodium bicarbonate

Substanzen

Sodium Bicarbonate

Autor:innen und Institutionen

  • Intensive Care Unit, Cairns Hospital, Cairns, Australia.
  • Department of Anaesthesia, Cairns Hospital, Cairns, Australia.
  • Intensive Care Services, Royal Brisbane and Women's Hospital, Herston, Australia.
  • School of Medicine, Faculty of Health, Queensland University of Technology, Brisbane, Australia.
  • Intensive Care Unit, Redcliffe Hospital, Redcliffe, Australia.
  • Faculty of Medicine, Mayne Academy of Critical Care, University of Queensland, St Lucia, Australia.

ORCID-Profile: Mahesh Ramanan

Förderung

  • Queensland University of Technology

Zitieren

APA

Blank, S. P., Blank, R. M., Laupland, K. B., Tabah, A., Gill, D., Kumar, A., White, K., Attokaran, A., Luke, S., Whebell, S., Garrett, P., McCullough, J., McIlroy, P., Ramanan, M., & Queensland Critical Care Research Network (QCCRN) (2025). Sodium bicarbonate administration for metabolic acidosis in the intensive care unit: a target trial emulation. Intensive Care Medicine, 51(6), 1078-1086. https://doi.org/10.1007/s00134-025-07979-x

Vancouver

Blank SP, Blank RM, Laupland KB, Tabah A, Gill D, Kumar A, et al. Sodium bicarbonate administration for metabolic acidosis in the intensive care unit: a target trial emulation. Intensive Care Medicine. 2025;51(6):1078-1086. doi:10.1007/s00134-025-07979-x

BibTeX
@article{Blank2025,
  author = {Blank, Sebastiaan Paul and Blank, Ruth Miriam and Laupland, Kevin B and Tabah, Alexis and Gill, Denzil and Kumar, Aashish and White, Kyle and Attokaran, Antony and Luke, Stephen and Whebell, Stephen and Garrett, Peter and McCullough, James and McIlroy, Philippa and Ramanan, Mahesh and Queensland Critical Care Research Network (QCCRN), Queensland Critical Care Research Network (QCCRN)},
  title = {Sodium bicarbonate administration for metabolic acidosis in the intensive care unit: a target trial emulation},
  journal = {Intensive Care Medicine},
  year = {2025},
  volume = {51},
  number = {6},
  pages = {1078--1086},
  doi = {10.1007/s00134-025-07979-x}
}
Kostenlos starten →